Background: Findings from a small clinical study suggested that statins may counteract the ther-apeutic effects of interferon beta (IFN) in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: We conducted a post hoc analysis of data from the Safety and Efficacy of Natalizumab in Combination With IFN-1a in Patients With Relapsing-Remitting Multiple Sclerosis (SENTINEL) study to determine the effects of statins on efficacy of IFN. SENTINEL was a prospective trial o
Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possibl...
Item does not contain fulltextBACKGROUND: Interferon beta is used to modify the course of relapsing ...
Background Interferon inhibitory activity (IIA) is a logical candidate for explaining neutralizing ...
Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects...
Abstract Statins have anti-inflammatory and immuno-modulatory properties in addition to lipid-loweri...
Recent studies support the notion that statins, widely prescribed cholesterol-lowering agents, may t...
Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects...
Background: Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowe...
Abstract—Background: Recent data suggest that statins may be potent immunomodulatory agents. In orde...
BACKGROUND Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lo...
Beneficial effects by both interferon-beta and statin treatment in patients with multiple sclerosis ...
A large body of evidence suggests that, besides their cholesterol-lowering effect, statins exert ant...
The SENTINEL study showed that the addition of natalizumab improved outcomes for patients with relap...
BACKGROUND: Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicat...
Objectives. Interferon-β (IFN-β) is used in the treatment of multiple sclerosis (MS). IFN-β activati...
Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possibl...
Item does not contain fulltextBACKGROUND: Interferon beta is used to modify the course of relapsing ...
Background Interferon inhibitory activity (IIA) is a logical candidate for explaining neutralizing ...
Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects...
Abstract Statins have anti-inflammatory and immuno-modulatory properties in addition to lipid-loweri...
Recent studies support the notion that statins, widely prescribed cholesterol-lowering agents, may t...
Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects...
Background: Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowe...
Abstract—Background: Recent data suggest that statins may be potent immunomodulatory agents. In orde...
BACKGROUND Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lo...
Beneficial effects by both interferon-beta and statin treatment in patients with multiple sclerosis ...
A large body of evidence suggests that, besides their cholesterol-lowering effect, statins exert ant...
The SENTINEL study showed that the addition of natalizumab improved outcomes for patients with relap...
BACKGROUND: Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicat...
Objectives. Interferon-β (IFN-β) is used in the treatment of multiple sclerosis (MS). IFN-β activati...
Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possibl...
Item does not contain fulltextBACKGROUND: Interferon beta is used to modify the course of relapsing ...
Background Interferon inhibitory activity (IIA) is a logical candidate for explaining neutralizing ...